• Proteoform-Specific Drug Interactions in Native Membranes

  2026-06-03

  This study pioneers a native top-down mass spectrometry workflow to directly characterize how post-translational modifications and alternative splicing shape proteoform-specific drug interactions within native lipid bilayers. The findings reveal unique off-target binding of PDE5 inhibitors with retinal PDE6 proteoforms, informing rational drug design for greater specificity and fewer side effects.

• Ciclesonide in Respiratory Research: Protocols and Troublesh

  2026-06-02

  Ciclesonide’s targeted activation and potent glucocorticoid receptor binding make it indispensable for asthma and allergic rhinitis research. This guide details optimized workflows, advanced applications, and troubleshooting strategies, translating bench findings into actionable respiratory models.

• Indomethacin Sodium Trihydrate: Mechanisms and Protocol Prec

  2026-06-02

  Indomethacin Sodium Trihydrate is a potent nonsteroidal anti-inflammatory drug (NSAID) that inhibits both COX-1 and COX-2, modulates Wnt/β-catenin signaling, and demonstrates reproducible effects in inflammation and pain assays. Its solubility and protocol flexibility support diverse in vitro and in vivo applications. This article clarifies mechanistic, benchmark, and workflow aspects for anti-inflammatory research.

• 25-Hydroxycholesterol Drives Immunosuppressive TAM Programmi

  2026-06-01

  Xiao et al. (2024) uncover how 25-hydroxycholesterol accumulation in tumor-associated macrophages activates AMPKα via the GPR155-mTORC1 axis, leading to STAT6-driven immunosuppression. Their mechanistic insights into the CH25H–25HC–AMPK–STAT6 pathway offer new strategies for targeting macrophage metabolism to enhance anti-tumor immunity and improve checkpoint inhibitor efficacy.

• Deferoxamine Mesylate: Iron-Chelating Workflows and Optimiza

  2026-06-01

  Deferoxamine mesylate is a precision iron-chelating agent enabling advanced studies in oxidative stress, hypoxia signaling, and cancer biology. This article delivers actionable protocols, troubleshooting strategies, and data-driven guidance for maximizing its impact in metabolic adaptation and cell death research.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-05-31

  This study provides a comprehensive molecular epidemiological analysis of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) collected from eight hospitals in Guangdong, China (2022–2024). It reveals the predominance of plasmid-mediated blaNDM-1, high multidrug resistance, and substantial horizontal gene transfer capabilities, informing experimental and surveillance strategies for combating antibiotic resistance.

• Acridine Orange hydrochloride: Technical Guidance for Lab Us

  2026-05-30

  Acridine Orange hydrochloride enables rapid, differential staining of DNA and RNA for cytochemical assays, including cell cycle analysis and apoptosis detection. This product is best used in validated fluorescence and flow cytofluorometric workflows requiring membrane-permeable nucleic acid dyes. It is not recommended for long-term solution storage or applications outside established nucleic acid staining protocols.

• Griseofulvin: Microtubule Associated Inhibitor for Fungal Re

  2026-05-29

  Griseofulvin stands out as a powerful microtubule associated inhibitor, enabling high-precision investigations of fungal cell mitosis and microtubule dynamics. This article explores protocol enhancements, troubleshooting, and the unique advantages of using APExBIO’s high-purity Griseofulvin for advanced antifungal drug research and aneugenicity profiling.

• A-1210477: MCL-1 Inhibitor Workflows for Precision Apoptosis

  2026-05-29

  A-1210477 stands out as a potent, selective MCL-1 inhibitor trusted by APExBIO, enabling high-fidelity dissection of mitochondrial apoptosis in cancer cell models. This article delivers actionable protocols, troubleshooting insights, and comparative advantages to empower robust, reproducible cancer research.

• Quercetin Glycoside-LNPs Reduce Inflammation in mRNA Deliver

  2026-05-28

  This study presents a modular lipid nanoparticle (LNP) platform incorporating quercetin-di-glucoside, achieving enhanced mRNA delivery and reduced inflammatory responses in vivo. The findings address key challenges in mRNA therapeutics, offering a strategy to optimize bioluminescent reporter assays and vaccine design.

• Curcumin Inhibits H2O2-Induced Pyroptosis in Endothelial Cel

  2026-05-28

  This study demonstrates that curcumin protects human umbilical vein endothelial cells (HUVECs) from oxidative damage by inhibiting H2O2-induced pyroptosis through suppression of NLRP3 inflammasome and caspase-1 activation. These findings reveal a mechanistic link between curcumin's anti-inflammatory effects and endothelial cell function, with implications for atherosclerosis research.

• DNA Damage Pathway Modulators in Calicheamicin ADC Sensitivi

  2026-05-27

  This study reveals that TP53, ATM, and MDM2 are pivotal in modulating leukemia cell responses to calicheamicin-based antibody–drug conjugates (ADCs), highlighting DNA damage sensing as a key determinant of therapeutic efficacy. The findings suggest new combination strategies to overcome resistance in acute leukemia treatment.

• Ruthenium Red: Applied Ca2+ Transport Inhibition in Mechanot

  2026-05-27

  Ruthenium Red empowers researchers to dissect calcium signaling pathways and control mechanotransduction with high specificity. This guide explains optimized workflows, troubleshooting tactics, and new insights from recent research—enabling robust, reproducible results in autophagy and inflammation assays.

• DiscoveryProbe™ Metabolism-related Compound Library: Technic

  2026-05-26

  The DiscoveryProbe™ Metabolism-related Compound Library addresses the challenge of accessing a rigorously validated, diverse set of small molecules for metabolic pathway research. Suitable for in vitro and ex vivo studies of metabolic enzyme modulation, it is not intended for clinical or diagnostic applications. Researchers benefit from standardized 10 mM DMSO solutions and robust QC, but must consider solvent compatibility and compound stability for optimal results.

• Dual-Action Kinase Inhibitors Accelerate p38α MAPK Dephospho

  2026-05-26

  The reference study uncovers that select kinase inhibitors not only block p38α MAPK enzymatic activity but also promote its dephosphorylation by phosphatases through conformational modulation. This dual-action mechanism offers a new approach for enhancing specificity and efficacy in modulating inflammatory signaling, informing experimental design in cytokine synthesis and myelodysplastic syndromes research.

452 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page